Transcripta Bio
PrivateLast Round
Early Funding
Jul 22, 2026
Total Funding Raised
$26.71M
Company Overview
Transcripta Bio is a biotechnology company that utilizes AI and high-resolution transcriptomic data to accelerate drug discovery and therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transcripta Bio Comparables
Compare Transcripta Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tahoe Therapeutics | 87% | |
| Arpeggio Biosciences | 85% | |
| Pepper Bio | 84% | |
Transcripta Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 22, 2026 | ||||
| VC Round | Apr 29, 2024 | ||||
| Series A | Nov 5, 2021 | ||||
| Grant | Oct 1, 2021 | ||||
| Seed | Nov 23, 2020 | ||||
Seed | Oct 12, 2020 |
Key People
Founding team and executive leadership
Transcripta Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prototype Capital | Seed |
| BlueYard Capital | Early Funding, Series A, VC Round, Seed |
| Gaingels | VC Round |
| JAZZ Venture Partners | Early Funding, Series A, VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
$24M raised with participation from BlueYard Capital and Mayo Clinic.
- May 30, 2025
Collaborating with Microsoft Research on AI applications for medicine.
Transcripta Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transcripta Bio's valuation, stock price, and market status.